메뉴 건너뛰기




Volumn , Issue , 2006, Pages 717-737

Secondary Osteoporosis

Author keywords

[No Author keywords available]

Indexed keywords


EID: 77956110454     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088562-6/50044-3     Document Type: Chapter
Times cited : (2)

References (189)
  • 2
    • 0017712007 scopus 로고
    • Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calciumphosphorous metabolism
    • Mosekilde L., Flemming M., Bagger J.P., Myhre-Jensen O., Sorensen N.S. Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calciumphosphorous metabolism. Acta. Endocrinologica. 1976, 85:515-525.
    • (1976) Acta. Endocrinologica. , vol.85 , pp. 515-525
    • Mosekilde, L.1    Flemming, M.2    Bagger, J.P.3    Myhre-Jensen, O.4    Sorensen, N.S.5
  • 4
    • 0022411495 scopus 로고
    • Trabecular bone remodeling and bone balance in hyperparathyroidism
    • Eriksen E.F., Mosekilde L., Melsen F. Trabecular bone remodeling and bone balance in hyperparathyroidism. Bone 1985, 6:421-428.
    • (1985) Bone , vol.6 , pp. 421-428
    • Eriksen, E.F.1    Mosekilde, L.2    Melsen, F.3
  • 8
    • 0018748637 scopus 로고
    • Osteoporosis in hyperthyroidism estimated by photon absorptiometry
    • Linde J., Friis T. Osteoporosis in hyperthyroidism estimated by photon absorptiometry. Acta. Endocrinolgica. 1979, 91:437-448.
    • (1979) Acta. Endocrinolgica. , vol.91 , pp. 437-448
    • Linde, J.1    Friis, T.2
  • 9
    • 0020583227 scopus 로고
    • Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and anti-thyroid treatment
    • Krolner B., Jorgensen J.V., Nielsen S.P. Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and anti-thyroid treatment. Clin. Endocrinol. 1983, 18:439-446.
    • (1983) Clin. Endocrinol. , vol.18 , pp. 439-446
    • Krolner, B.1    Jorgensen, J.V.2    Nielsen, S.P.3
  • 10
    • 0028153535 scopus 로고
    • Thyrotoxic bone disease in women: a potentially reversible disorder
    • Diamond T., Vine J., Smart R., Butler P. Thyrotoxic bone disease in women: a potentially reversible disorder. Ann. Intern. Med. 1994, 120:8-11.
    • (1994) Ann. Intern. Med. , vol.120 , pp. 8-11
    • Diamond, T.1    Vine, J.2    Smart, R.3    Butler, P.4
  • 13
    • 0026716868 scopus 로고
    • Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism
    • Rosen C.J., Adler R.A. Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J. Clin. Endocrinol. Metab. 1992, 75:1531-1534.
    • (1992) J. Clin. Endocrinol. Metab. , vol.75 , pp. 1531-1534
    • Rosen, C.J.1    Adler, R.A.2
  • 14
    • 0015225556 scopus 로고
    • Osteoporosis and fractures following thyrotoxicosis
    • Fraser S.A., Anderson J.B., Smith D.A., Wilson G.M. Osteoporosis and fractures following thyrotoxicosis. Lancet 1971, 1:981-983.
    • (1971) Lancet , vol.1 , pp. 981-983
    • Fraser, S.A.1    Anderson, J.B.2    Smith, D.A.3    Wilson, G.M.4
  • 15
    • 0021846223 scopus 로고
    • Effect of hyperthyroidism and its treatment on bone mineral content
    • Toh S.H., Claunch B.C., Brown P.H. Effect of hyperthyroidism and its treatment on bone mineral content. Arch. Intern. Med. 1985, 145:883-886.
    • (1985) Arch. Intern. Med. , vol.145 , pp. 883-886
    • Toh, S.H.1    Claunch, B.C.2    Brown, P.H.3
  • 16
    • 0025278627 scopus 로고
    • Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism
    • Lee M.S., Kim S.Y., Lee M.C., Cho B.Y., Lee H.K., Koh C., Min H.K. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J. Clin. Endocrinol. Metab. 1990, 70:766-770.
    • (1990) J. Clin. Endocrinol. Metab. , vol.70 , pp. 766-770
    • Lee, M.S.1    Kim, S.Y.2    Lee, M.C.3    Cho, B.Y.4    Lee, H.K.5    Koh, C.6    Min, H.K.7
  • 22
    • 0028111183 scopus 로고
    • Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease
    • Garnero P., Gineyts E., Riou J.P., Delmas P.D. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J. Clin. Endocrinol. Metab. 1994, 79:780-785.
    • (1994) J. Clin. Endocrinol. Metab. , vol.79 , pp. 780-785
    • Garnero, P.1    Gineyts, E.2    Riou, J.P.3    Delmas, P.D.4
  • 24
    • 0028103839 scopus 로고
    • Bone mineral density in thyroxine treated femals with our without a previous history of thyrotoxicosis
    • Franklyn J., Betteridge J., Holder R., Daykin J., Lilley J., Sheppard M. Bone mineral density in thyroxine treated femals with our without a previous history of thyrotoxicosis. Clin. Endocrinol. 1994, 41:425-432.
    • (1994) Clin. Endocrinol. , vol.41 , pp. 425-432
    • Franklyn, J.1    Betteridge, J.2    Holder, R.3    Daykin, J.4    Lilley, J.5    Sheppard, M.6
  • 25
    • 0025905961 scopus 로고
    • Bone mineral density in postmenopausal women treated with L-thyroxine
    • Adlin E.V., Maurer A.H., Marks A.D., Channick B.J. Bone mineral density in postmenopausal women treated with L-thyroxine. Am. J. Med. 1991, 90:360-366.
    • (1991) Am. J. Med. , vol.90 , pp. 360-366
    • Adlin, E.V.1    Maurer, A.H.2    Marks, A.D.3    Channick, B.J.4
  • 27
    • 0026751673 scopus 로고
    • Peripheral bone density in women with untreated multinodular goitre
    • Mudde A.H., Reijnders F.J.S., Kruseman A.C.N. Peripheral bone density in women with untreated multinodular goitre. Clin. Endocrinol. 1992, 37:35-39.
    • (1992) Clin. Endocrinol. , vol.37 , pp. 35-39
    • Mudde, A.H.1    Reijnders, F.J.S.2    Kruseman, A.C.N.3
  • 28
    • 84882472285 scopus 로고
    • Bone mineral content in premenopausal women with nontoxic goiter and reduced serum TSH
    • th meeting
    • Faber J., Overgaard K., Jarlow A. Bone mineral content in premenopausal women with nontoxic goiter and reduced serum TSH. Abstract 1 1992.
    • (1992) Abstract 1
    • Faber, J.1    Overgaard, K.2    Jarlow, A.3
  • 29
    • 0027434963 scopus 로고
    • Bone mineral density in patients with endogenous subclincal hyperthyroidism: Is this thyroid status a risk factor for osteoporosis?
    • Foldes J., Tarjan G., Szathmari M., Varga F., Krasznai I., Horvath C.S. Bone mineral density in patients with endogenous subclincal hyperthyroidism: Is this thyroid status a risk factor for osteoporosis?. Clin. Endocrinol. 1993, 39:521-527.
    • (1993) Clin. Endocrinol. , vol.39 , pp. 521-527
    • Foldes, J.1    Tarjan, G.2    Szathmari, M.3    Varga, F.4    Krasznai, I.5    Horvath, C.S.6
  • 30
    • 0031931052 scopus 로고    scopus 로고
    • Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism effect on bone loss in postmenopausal women
    • Faber J., Jensen W., Petersen L., Nygaard B., Hegedus L., Siersbaek-Nielsen K. Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism effect on bone loss in postmenopausal women. Clin. Endocrinol. 1998, 48:285-290.
    • (1998) Clin. Endocrinol. , vol.48 , pp. 285-290
    • Faber, J.1    Jensen, W.2    Petersen, L.3    Nygaard, B.4    Hegedus, L.5    Siersbaek-Nielsen, K.6
  • 31
    • 0025057667 scopus 로고
    • Bone gla protein and sex-hormone-binding globulin in nontoxic goiter parameters for metabolic status at the tissue level
    • Faber J., Perrild H., Johansen J.S. Bone gla protein and sex-hormone-binding globulin in nontoxic goiter parameters for metabolic status at the tissue level. J. Clin. Endocrinol. Metab. 1990, 70:49-55.
    • (1990) J. Clin. Endocrinol. Metab. , vol.70 , pp. 49-55
    • Faber, J.1    Perrild, H.2    Johansen, J.S.3
  • 33
    • 0942276916 scopus 로고    scopus 로고
    • Bone and calcium metabolism in subclinical autoimmune hyperthyroidism and hypothyroidism
    • Kisakol G., Kaya A., Gonen S., Tunc R. Bone and calcium metabolism in subclinical autoimmune hyperthyroidism and hypothyroidism. Endocrine J. 2003, 50:657-661.
    • (2003) Endocrine J. , vol.50 , pp. 657-661
    • Kisakol, G.1    Kaya, A.2    Gonen, S.3    Tunc, R.4
  • 34
    • 1842333256 scopus 로고    scopus 로고
    • Decreased serum IGF-1 and dehydroepian drosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subelinical hyperthyroidism
    • Foldes J., Lakatos P., Zsadanyi J., Horvath C. Decreased serum IGF-1 and dehydroepian drosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subelinical hyperthyroidism. Eur. J. Endocrinol. 1997, 136:277-281.
    • (1997) Eur. J. Endocrinol. , vol.136 , pp. 277-281
    • Foldes, J.1    Lakatos, P.2    Zsadanyi, J.3    Horvath, C.4
  • 36
    • 0023624938 scopus 로고
    • Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine
    • Ross D.S., Neer R.M., Ridgway E.C., Daniels G.H. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am. J. Med. 1987, 82:1167-1170.
    • (1987) Am. J. Med. , vol.82 , pp. 1167-1170
    • Ross, D.S.1    Neer, R.M.2    Ridgway, E.C.3    Daniels, G.H.4
  • 37
    • 0023890201 scopus 로고
    • Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women
    • Paul T.L., Kerrigan J., Kelly A.M., Braverman L.E., Baran D.T. Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA 1988, 259:3137-3141.
    • (1988) JAMA , vol.259 , pp. 3137-3141
    • Paul, T.L.1    Kerrigan, J.2    Kelly, A.M.3    Braverman, L.E.4    Baran, D.T.5
  • 38
    • 0025140523 scopus 로고
    • Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine
    • Staff G.M., Harris S., Sokoll L.J., Dawson-Hughes B. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Annals. Int. Med. 1990, 113:265-269.
    • (1990) Annals. Int. Med. , vol.113 , pp. 265-269
    • Staff, G.M.1    Harris, S.2    Sokoll, L.J.3    Dawson-Hughes, B.4
  • 39
    • 0025880181 scopus 로고
    • A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal woman with thyroid carcinoma
    • Diamond T., Nery L., Hales I. A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal woman with thyroid carcinoma. J. Clin. Endocrinol. Metab. 1990, 72:1184-1188.
    • (1990) J. Clin. Endocrinol. Metab. , vol.72 , pp. 1184-1188
    • Diamond, T.1    Nery, L.2    Hales, I.3
  • 40
    • 0027496389 scopus 로고
    • Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women
    • Kung A.W.C., Lorentz T., Tam S.C.F. Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women. Clin. Endocrinol. 1993, 39:535-540.
    • (1993) Clin. Endocrinol. , vol.39 , pp. 535-540
    • Kung, A.W.C.1    Lorentz, T.2    Tam, S.C.F.3
  • 41
    • 0028324355 scopus 로고
    • Thyroid hormone use and bone mineral density in elderly women
    • Schneider D.L., Barrett-Connor E.L., Morton D.J. Thyroid hormone use and bone mineral density in elderly women. JAMA 1994, 271:1245-1249.
    • (1994) JAMA , vol.271 , pp. 1245-1249
    • Schneider, D.L.1    Barrett-Connor, E.L.2    Morton, D.J.3
  • 42
    • 0035486993 scopus 로고    scopus 로고
    • Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone
    • Sijanovic S., Karner I. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone. Medscape Womens Health 2001, 6:3-7.
    • (2001) Medscape Womens Health , vol.6 , pp. 3-7
    • Sijanovic, S.1    Karner, I.2
  • 43
    • 0025862046 scopus 로고
    • Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH
    • Gam A.N., Jensen G.F., Hasselstrom K., Olsen M., Nielsen K.S. Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH. J. Endocrinol. Invest. 1991, 14:451-455.
    • (1991) J. Endocrinol. Invest. , vol.14 , pp. 451-455
    • Gam, A.N.1    Jensen, G.F.2    Hasselstrom, K.3    Olsen, M.4    Nielsen, K.S.5
  • 46
  • 47
    • 0030986513 scopus 로고    scopus 로고
    • Low thyrotropin levels are not associated with bone loss in older women: a prospective study
    • Bauer D.C., Nevitt M.C., Ettinger B., Stone K. Low thyrotropin levels are not associated with bone loss in older women: a prospective study. J. Clin. Endocrinol. Metab. 1997, 82:2931-2936.
    • (1997) J. Clin. Endocrinol. Metab. , vol.82 , pp. 2931-2936
    • Bauer, D.C.1    Nevitt, M.C.2    Ettinger, B.3    Stone, K.4
  • 49
    • 0025897209 scopus 로고
    • Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism
    • Ross D.S., Ardisson L.J., Nussbaum S.R., Meskell M.J. Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism. J. Clin. Endocrinol. Metab. 1990, 72:507-509.
    • (1990) J. Clin. Endocrinol. Metab. , vol.72 , pp. 507-509
    • Ross, D.S.1    Ardisson, L.J.2    Nussbaum, S.R.3    Meskell, M.J.4
  • 50
    • 0035043983 scopus 로고    scopus 로고
    • Suppressive levothyroxine therapy has no significant influence on bone degradation in women with thyroid carcinoma: a comparison with other disorders affecting bone metabolism
    • Mikosch P., Jauk B., Gallowitsch H.J., Pipam W., Kresnik E., Lind P. Suppressive levothyroxine therapy has no significant influence on bone degradation in women with thyroid carcinoma: a comparison with other disorders affecting bone metabolism. Thyroid 2001, 11:257-263.
    • (2001) Thyroid , vol.11 , pp. 257-263
    • Mikosch, P.1    Jauk, B.2    Gallowitsch, H.J.3    Pipam, W.4    Kresnik, E.5    Lind, P.6
  • 51
    • 2642617814 scopus 로고    scopus 로고
    • Markers of bone tumover in patients with differentiated thyroid cancer with and following withdrawal of thyroxine suppressive therapy
    • Toivonen J., Tahtela R., Laitinen K., Risteli J., Valimaki M.J. Markers of bone tumover in patients with differentiated thyroid cancer with and following withdrawal of thyroxine suppressive therapy. Eur. J. Endocrinol. 1998, 138:667-673.
    • (1998) Eur. J. Endocrinol. , vol.138 , pp. 667-673
    • Toivonen, J.1    Tahtela, R.2    Laitinen, K.3    Risteli, J.4    Valimaki, M.J.5
  • 52
    • 0028296041 scopus 로고
    • Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis
    • Faber J., Galloe A.M. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur. J. Endocrinol. 1994, 130:350-356.
    • (1994) Eur. J. Endocrinol. , vol.130 , pp. 350-356
    • Faber, J.1    Galloe, A.M.2
  • 54
    • 0025744590 scopus 로고
    • Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers
    • Harvey R.D., McHardy K.C., Reid I.W., Paterson F., Bewsher P.D., Duncan A., Robins S.P. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. J. Clin. Endocrinol. Metab. 1991, 72:1189-1194.
    • (1991) J. Clin. Endocrinol. Metab. , vol.72 , pp. 1189-1194
    • Harvey, R.D.1    McHardy, K.C.2    Reid, I.W.3    Paterson, F.4    Bewsher, P.D.5    Duncan, A.6    Robins, S.P.7
  • 56
    • 0030936418 scopus 로고    scopus 로고
    • Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine
    • Guo C.Y., Weetman A.P., Eastell R. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine. Clin. Endocrinol. 1997, 46:301-307.
    • (1997) Clin. Endocrinol. , vol.46 , pp. 301-307
    • Guo, C.Y.1    Weetman, A.P.2    Eastell, R.3
  • 57
    • 0031784573 scopus 로고    scopus 로고
    • Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate
    • Rosen H.N., Moses A.C., Garber J., Ross D.S., Lee S.L., Ferguson L., Chen V., Lee K., Greenspan S.L. Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate. J. Clin. Endocrinol. Metab. 1998, 83:2324-2330.
    • (1998) J. Clin. Endocrinol. Metab. , vol.83 , pp. 2324-2330
    • Rosen, H.N.1    Moses, A.C.2    Garber, J.3    Ross, D.S.4    Lee, S.L.5    Ferguson, L.6    Chen, V.7    Lee, K.8    Greenspan, S.L.9
  • 58
    • 0029866430 scopus 로고    scopus 로고
    • Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin
    • Kung A.W., Yeung S.S. Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin. J. Clin. Endocrinol. Metab. 1996, 81:1232-1236.
    • (1996) J. Clin. Endocrinol. Metab. , vol.81 , pp. 1232-1236
    • Kung, A.W.1    Yeung, S.S.2
  • 60
    • 0030038975 scopus 로고    scopus 로고
    • Role of growth hormone and sex steroids in achieving and maintaining normal bone mass
    • Holmes S.J., Shalet S.M. Role of growth hormone and sex steroids in achieving and maintaining normal bone mass. Horm. Res. 1996, 45:86-93.
    • (1996) Horm. Res. , vol.45 , pp. 86-93
    • Holmes, S.J.1    Shalet, S.M.2
  • 61
    • 0024957154 scopus 로고
    • The peak bone mass concept
    • Burckardt P., Michel C. The peak bone mass concept. Clin. Rheumatol. 1989, 8(Suppl 2):16-21.
    • (1989) Clin. Rheumatol. , vol.8 , Issue.SUPPL.2 , pp. 16-21
    • Burckardt, P.1    Michel, C.2
  • 63
    • 0025723535 scopus 로고
    • Functional estrogen receptors in osteoblastic cells demonstrated by transfection with a reporter gene containing an estrogen response element
    • Ernst M., Parkert M.G., Rodan G.A. Functional estrogen receptors in osteoblastic cells demonstrated by transfection with a reporter gene containing an estrogen response element. Mol. Endocrinol. 1991, 5:1597-1606.
    • (1991) Mol. Endocrinol. , vol.5 , pp. 1597-1606
    • Ernst, M.1    Parkert, M.G.2    Rodan, G.A.3
  • 64
    • 0027174296 scopus 로고
    • Cytokines and extrogen in bone: Anti-osteoporotic effects
    • Horowitz M.C. Cytokines and extrogen in bone: Anti-osteoporotic effects. Science 1993, 260:626-627.
    • (1993) Science , vol.260 , pp. 626-627
    • Horowitz, M.C.1
  • 65
    • 49749223893 scopus 로고
    • A sex-chromosome anomaly in a case of gonadal dysgenesis (Tumer's Syndrome)
    • Ford C.E., Jones K.W., Polani P.E., de Almeida J.C., Briggs J.H. A sex-chromosome anomaly in a case of gonadal dysgenesis (Tumer's Syndrome). Lancet 1959, 1:711-713.
    • (1959) Lancet , vol.1 , pp. 711-713
    • Ford, C.E.1    Jones, K.W.2    Polani, P.E.3    de Almeida, J.C.4    Briggs, J.H.5
  • 66
    • 0015692990 scopus 로고
    • Orthopedic aspects of the XO (Tumer's) syndrome
    • Beal R.K. Orthopedic aspects of the XO (Tumer's) syndrome. Clin. Orthopaed. Relat. Res. 1973, 97:19-30.
    • (1973) Clin. Orthopaed. Relat. Res. , vol.97 , pp. 19-30
    • Beal, R.K.1
  • 67
    • 0029562543 scopus 로고
    • Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea
    • Davies M.C., Gulekli B., Jacobs H.S. Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea. Clin. Endocrinol. 1995, 43:741-746.
    • (1995) Clin. Endocrinol. , vol.43 , pp. 741-746
    • Davies, M.C.1    Gulekli, B.2    Jacobs, H.S.3
  • 69
    • 0026605187 scopus 로고
    • Effect of estrogen replacement therapy on bone mineral content in girls with Turner's syndrome
    • Mora S., Weber G., Guameri M.P., Nizzoli G., Pasolini D., Chiumello G. Effect of estrogen replacement therapy on bone mineral content in girls with Turner's syndrome. Obstet. Gynecol. 1992, 79:747-751.
    • (1992) Obstet. Gynecol. , vol.79 , pp. 747-751
    • Mora, S.1    Weber, G.2    Guameri, M.P.3    Nizzoli, G.4    Pasolini, D.5    Chiumello, G.6
  • 70
    • 0020026238 scopus 로고
    • Bone demineralisation in patients with Turner's syndrome
    • Smith M.A., Wilson J., Price W.H. Bone demineralisation in patients with Turner's syndrome. J. Med. Genet. 1982, 19:100-103.
    • (1982) J. Med. Genet. , vol.19 , pp. 100-103
    • Smith, M.A.1    Wilson, J.2    Price, W.H.3
  • 71
    • 0026000858 scopus 로고
    • Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome
    • Ross J.L., Long L.M., Feuillan P., Cassorla F., Cutler G.B. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome. J. Clin. Endocrinol. Metab. 1991, 73:355-359.
    • (1991) J. Clin. Endocrinol. Metab. , vol.73 , pp. 355-359
    • Ross, J.L.1    Long, L.M.2    Feuillan, P.3    Cassorla, F.4    Cutler, G.B.5
  • 75
    • 0027304654 scopus 로고
    • Effect of hormone replacement therapy on spinal bone mineral density and T lymphocyte sub sets in premature ovarian failure and Turner's syndrome
    • Kurabayashi T., Yasuda M., Fujimaki T., Yamamoto Y., Oda K., Tanaka K. Effect of hormone replacement therapy on spinal bone mineral density and T lymphocyte sub sets in premature ovarian failure and Turner's syndrome. Int. J. Gynecol. Obstet. 1993, 42:25-31.
    • (1993) Int. J. Gynecol. Obstet. , vol.42 , pp. 25-31
    • Kurabayashi, T.1    Yasuda, M.2    Fujimaki, T.3    Yamamoto, Y.4    Oda, K.5    Tanaka, K.6
  • 76
    • 0024558228 scopus 로고
    • Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome
    • Stepan J.J., Musilova J., Pacovsky V. Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome. J. Bone Min. Res. 1989, 4:193-198.
    • (1989) J. Bone Min. Res. , vol.4 , pp. 193-198
    • Stepan, J.J.1    Musilova, J.2    Pacovsky, V.3
  • 77
    • 0024349443 scopus 로고
    • Bone loss in young hypoestrogenic women due to primary ovarian failure: spinal quantitative computed tomography
    • Louis O., Devroey P., Kalender W., Osteaux M. Bone loss in young hypoestrogenic women due to primary ovarian failure: spinal quantitative computed tomography. Fertil. Steril. 1989, 52:227-231.
    • (1989) Fertil. Steril. , vol.52 , pp. 227-231
    • Louis, O.1    Devroey, P.2    Kalender, W.3    Osteaux, M.4
  • 78
    • 0033814697 scopus 로고    scopus 로고
    • Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients
    • Carrascosa A., Gussinye M., Terradas P., Yeste D., Audi L., Vicens-Calvet E. Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients. J. Bone Miner. Res. 2000, 15:2005-2010.
    • (2000) J. Bone Miner. Res. , vol.15 , pp. 2005-2010
    • Carrascosa, A.1    Gussinye, M.2    Terradas, P.3    Yeste, D.4    Audi, L.5    Vicens-Calvet, E.6
  • 79
    • 0346656715 scopus 로고    scopus 로고
    • The importance of estrogen replacement in young women with Turmer's syndrome
    • Hanton L., Axelrod L., Bakalov V., Bondy C.A. The importance of estrogen replacement in young women with Turmer's syndrome. J. Womens Health 2003, 12:971-977.
    • (2003) J. Womens Health , vol.12 , pp. 971-977
    • Hanton, L.1    Axelrod, L.2    Bakalov, V.3    Bondy, C.A.4
  • 80
    • 0025102639 scopus 로고
    • Estrogen deficiency in adolescents and young adults: Impact on bone mineral content and effects of estrogen replacement therapy
    • Emans S.J., Grace E., Hoffer F.A., Gundberg C., Ravnikar V., Woods E.R. Estrogen deficiency in adolescents and young adults: Impact on bone mineral content and effects of estrogen replacement therapy. Obstet. Gynecol. 1990, 76:585-592.
    • (1990) Obstet. Gynecol. , vol.76 , pp. 585-592
    • Emans, S.J.1    Grace, E.2    Hoffer, F.A.3    Gundberg, C.4    Ravnikar, V.5    Woods, E.R.6
  • 81
    • 0028060326 scopus 로고
    • Effect of treatment on established osteoporosis in young women with amenorrhoea
    • Gulekli B., Davies M.C., Jacobs H.S. Effect of treatment on established osteoporosis in young women with amenorrhoea. Clin. Endocrinol. 1994, 41:275-281.
    • (1994) Clin. Endocrinol. , vol.41 , pp. 275-281
    • Gulekli, B.1    Davies, M.C.2    Jacobs, H.S.3
  • 82
    • 0037932676 scopus 로고    scopus 로고
    • Bone mineral density in adult patients with Turner's syndrome: Analyses of the effectiveness of GH and ovarian steroid homone replacement therapies
    • Suganuma N., Furuhashi M., Hirooka T., Moriwaki T., Hasegawa Y., Mori O., Ogawa M. Bone mineral density in adult patients with Turner's syndrome: Analyses of the effectiveness of GH and ovarian steroid homone replacement therapies. Endocrine J. 2003, 50:263-269.
    • (2003) Endocrine J. , vol.50 , pp. 263-269
    • Suganuma, N.1    Furuhashi, M.2    Hirooka, T.3    Moriwaki, T.4    Hasegawa, Y.5    Mori, O.6    Ogawa, M.7
  • 85
    • 0026732719 scopus 로고
    • Mineral metabolism in Turner's syndrome: evidence for impaired renal vitamin D metabolism and normal osteoblast function
    • Saggese G., Federico G., Bertelloni S., Baroncelli G.I. Mineral metabolism in Turner's syndrome: evidence for impaired renal vitamin D metabolism and normal osteoblast function. J. Clin. Endocrinol. Metab. 1992, 75:998-1001.
    • (1992) J. Clin. Endocrinol. Metab. , vol.75 , pp. 998-1001
    • Saggese, G.1    Federico, G.2    Bertelloni, S.3    Baroncelli, G.I.4
  • 87
    • 0019456781 scopus 로고
    • Urinary total hydroxiproline excretion in patients with Turner's sydroome and Klinefelter's syndrome
    • Jakubowski L. Urinary total hydroxiproline excretion in patients with Turner's sydroome and Klinefelter's syndrome. Horm. Metab. Res. 1981, 13:399-403.
    • (1981) Horm. Metab. Res. , vol.13 , pp. 399-403
    • Jakubowski, L.1
  • 88
    • 0028872902 scopus 로고
    • Increased urinary excretion of collagen crosslinks in girls with Ullrich-Turner syndrome
    • Rauch F., Seibel M., Woitge H., Kruse K., Schonau E. Increased urinary excretion of collagen crosslinks in girls with Ullrich-Turner syndrome. Acta. Paediatr. 1995, 84:66-69.
    • (1995) Acta. Paediatr. , vol.84 , pp. 66-69
    • Rauch, F.1    Seibel, M.2    Woitge, H.3    Kruse, K.4    Schonau, E.5
  • 89
    • 0027270978 scopus 로고
    • The somatotropin-somatomedin axis in adult patients with Turner syndrome: Measurements of stimulated GH, GH-BP, IGF-I, IGF-II and IGFBP-3 in 25 patients
    • Holl R.W., Kunze D., Blum W.F., Benz R., Etzrodt H., Heinze The somatotropin-somatomedin axis in adult patients with Turner syndrome: Measurements of stimulated GH, GH-BP, IGF-I, IGF-II and IGFBP-3 in 25 patients. Horm. Res. 1993, 39:30-53.
    • (1993) Horm. Res. , vol.39 , pp. 30-53
    • Holl, R.W.1    Kunze, D.2    Blum, W.F.3    Benz, R.4    Etzrodt, H.5    Heinze6
  • 91
    • 0028819596 scopus 로고
    • Plasma growth hormone-binding protein activity, insulin like growth factor I, and its binding protein levels patpatients with Turner's syndrome: effect of short- and long-term recombinant growth hormone administration
    • Saggese G., Federico G., Cinquanta L. Plasma growth hormone-binding protein activity, insulin like growth factor I, and its binding protein levels patpatients with Turner's syndrome: effect of short- and long-term recombinant growth hormone administration. Pediatr. Res. 1995, 37:106-111.
    • (1995) Pediatr. Res. , vol.37 , pp. 106-111
    • Saggese, G.1    Federico, G.2    Cinquanta, L.3
  • 92
    • 0026757517 scopus 로고
    • Growth hormone therapy in Turner's syndrome: an update on final heights
    • Rosenfeld R.G. Growth hormone therapy in Turner's syndrome: an update on final heights. Acta. Paediat. Scand. 1992, 383(Suppl):3-6.
    • (1992) Acta. Paediat. Scand. , vol.383 , Issue.SUPPL. , pp. 3-6
    • Rosenfeld, R.G.1
  • 93
    • 84882517652 scopus 로고
    • The effect of marathon training upon menstrual function
    • Shangold M.M., Levine H.S. The effect of marathon training upon menstrual function. Am. J. Obstet. Gynecol. 1979, 54:47.
    • (1979) Am. J. Obstet. Gynecol. , vol.54 , pp. 47
    • Shangold, M.M.1    Levine, H.S.2
  • 95
    • 0019135039 scopus 로고
    • The effect of exercise on pubertal progression and reproductive functions in girls
    • Warren M.P. The effect of exercise on pubertal progression and reproductive functions in girls. J. Clin. Endocrinol. Metab. 1980, 51:1150-1157.
    • (1980) J. Clin. Endocrinol. Metab. , vol.51 , pp. 1150-1157
    • Warren, M.P.1
  • 100
    • 0030018643 scopus 로고    scopus 로고
    • Bone density at multiple skeletal sites in amenorrheic athletes
    • Rencken M.L., Chesnut C.H., Drinkwater B.L. Bone density at multiple skeletal sites in amenorrheic athletes. JAMA 1996, 276:238-240.
    • (1996) JAMA , vol.276 , pp. 238-240
    • Rencken, M.L.1    Chesnut, C.H.2    Drinkwater, B.L.3
  • 101
    • 0019967349 scopus 로고
    • The differential effects of endocrine dysfunction on the axial and appendicular skeleton
    • Seeman E., Wahner H.W., Offord K.P., Johnson W.J., Riggs B.L. The differential effects of endocrine dysfunction on the axial and appendicular skeleton. J. Clin. Invest. 1982, 69:1302-1309.
    • (1982) J. Clin. Invest. , vol.69 , pp. 1302-1309
    • Seeman, E.1    Wahner, H.W.2    Offord, K.P.3    Johnson, W.J.4    Riggs, B.L.5
  • 102
    • 84995842587 scopus 로고
    • Bone density at weight-bearing and nonweight-bearing sites in ballet dancers: the effect of exercise, hypogonadism, and body weight
    • Young N., Formica C., Szmukler G., Seeman E. Bone density at weight-bearing and nonweight-bearing sites in ballet dancers: the effect of exercise, hypogonadism, and body weight. J. Clin. Endocrinol. Metab. 1994, 78:449-454.
    • (1994) J. Clin. Endocrinol. Metab. , vol.78 , pp. 449-454
    • Young, N.1    Formica, C.2    Szmukler, G.3    Seeman, E.4
  • 103
    • 0028953822 scopus 로고
    • Gymnasts exhibit higher bone mass than runners despite similar prevalence of amenorrhea and oligomenorrhea
    • Robinson T.L., Snow-Harter C., Taaffe D.R., Gillis D., Shaw J., Marcus R. Gymnasts exhibit higher bone mass than runners despite similar prevalence of amenorrhea and oligomenorrhea. J. Bone Min. Res. 1995, 10:26-35.
    • (1995) J. Bone Min. Res. , vol.10 , pp. 26-35
    • Robinson, T.L.1    Snow-Harter, C.2    Taaffe, D.R.3    Gillis, D.4    Shaw, J.5    Marcus, R.6
  • 104
    • 0027447266 scopus 로고
    • High intensity activities in young women: Site specific bone mass effects among fenale figure skaters
    • Slemenda C.W., Johnston C.C. High intensity activities in young women: Site specific bone mass effects among fenale figure skaters. Bone Miner. Res. 1993, 20:125-132.
    • (1993) Bone Miner. Res. , vol.20 , pp. 125-132
    • Slemenda, C.W.1    Johnston, C.C.2
  • 106
    • 11244250669 scopus 로고    scopus 로고
    • The assessment of bone metabolism in female elite endurance athletes by biochenical bone markers
    • Herrmann M., Herrmann W. The assessment of bone metabolism in female elite endurance athletes by biochenical bone markers. Clin. Chem. Lab. Med. 2004, 42:1384-1389.
    • (2004) Clin. Chem. Lab. Med. , vol.42 , pp. 1384-1389
    • Herrmann, M.1    Herrmann, W.2
  • 107
    • 0031814857 scopus 로고    scopus 로고
    • Relation between bone turnover, estradiol, and energy balance in women distance runners
    • Zanker C.L., Swaine I.L. Relation between bone turnover, estradiol, and energy balance in women distance runners. Br. J. Sports. Med. 1998, 32:167-171.
    • (1998) Br. J. Sports. Med. , vol.32 , pp. 167-171
    • Zanker, C.L.1    Swaine, I.L.2
  • 112
    • 0029081214 scopus 로고
    • Bone metabolism and osteopenia in eatingg disorders
    • Carmichael K.A., Carmichael D.H. Bone metabolism and osteopenia in eatingg disorders. Medicine 1995, 74:254-267.
    • (1995) Medicine , vol.74 , pp. 254-267
    • Carmichael, K.A.1    Carmichael, D.H.2
  • 114
    • 0026030364 scopus 로고
    • The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass
    • Rigotti N.A., Neer R.M., Skates S.J., Herzog D.B., Nussbaum S.R. The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA 1991, 265:1133-1138.
    • (1991) JAMA , vol.265 , pp. 1133-1138
    • Rigotti, N.A.1    Neer, R.M.2    Skates, S.J.3    Herzog, D.B.4    Nussbaum, S.R.5
  • 117
    • 0023000663 scopus 로고
    • Osteoporosis and hip fracture in a young woman with anorexia nervosa
    • Kaplan F.S., Pertschuck M., Fallon M., Haddad J. Osteoporosis and hip fracture in a young woman with anorexia nervosa. Clin. Orthop. 1986, 212:250-254.
    • (1986) Clin. Orthop. , vol.212 , pp. 250-254
    • Kaplan, F.S.1    Pertschuck, M.2    Fallon, M.3    Haddad, J.4
  • 118
    • 0025305043 scopus 로고
    • Osteoporosis in women with eating disorders: comparison of physical parameters, exercise, and menstrual status with SPA and DPA evaluation
    • Joyce J.M., Warren D.L., Humphries L.L., Smith A.J., Coon J.S. Osteoporosis in women with eating disorders: comparison of physical parameters, exercise, and menstrual status with SPA and DPA evaluation. J. Nucl. Med. 1990, 31:325-331.
    • (1990) J. Nucl. Med. , vol.31 , pp. 325-331
    • Joyce, J.M.1    Warren, D.L.2    Humphries, L.L.3    Smith, A.J.4    Coon, J.S.5
  • 120
    • 0029799208 scopus 로고    scopus 로고
    • Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa
    • Grinspoon S., Baum H., Lee K., Anderson E., Herzog D., Klibanski A. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J. Clin. Endocrinol. Metab. 1996, 81:3864-3870.
    • (1996) J. Clin. Endocrinol. Metab. , vol.81 , pp. 3864-3870
    • Grinspoon, S.1    Baum, H.2    Lee, K.3    Anderson, E.4    Herzog, D.5    Klibanski, A.6
  • 121
    • 0024619323 scopus 로고
    • Osteoporose trabeculaire compliquant une anorexia mentale meconnue
    • Maugars Y., Prost A. Osteoporose trabeculaire compliquant une anorexia mentale meconnue. Rev. Rhum. Mal. Osteoartic. 1989, 56:159-161.
    • (1989) Rev. Rhum. Mal. Osteoartic. , vol.56 , pp. 159-161
    • Maugars, Y.1    Prost, A.2
  • 123
    • 0035187205 scopus 로고    scopus 로고
    • Osteoporosis in eating disorders: A follow-up study of patients with anorexiaa and bulimia nervosa
    • Zipfel S., Seibel M.J., Lowe B., Beumont P.J., Kasperk C., Herzog W. Osteoporosis in eating disorders: A follow-up study of patients with anorexiaa and bulimia nervosa. J. Clin. Endocrinol Metab. 2001, 86:5227-5233.
    • (2001) J. Clin. Endocrinol Metab. , vol.86 , pp. 5227-5233
    • Zipfel, S.1    Seibel, M.J.2    Lowe, B.3    Beumont, P.J.4    Kasperk, C.5    Herzog, W.6
  • 125
    • 0021260628 scopus 로고
    • Development of cushing's disease in patient with anorexia nervosa
    • Kontula K., Mustajoki P., Pelkonen R. Development of cushing's disease in patient with anorexia nervosa. J. Endocrinol. Invest. 1984, 7:35-40.
    • (1984) J. Endocrinol. Invest. , vol.7 , pp. 35-40
    • Kontula, K.1    Mustajoki, P.2    Pelkonen, R.3
  • 126
    • 0026775341 scopus 로고
    • The effects of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins
    • Counts D.R., Gwirtsman H., Carlsson L.M., Lesem M., Cutler G.B. The effects of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J. Clin. Endocrinol. Metab. 1992, 75:762-767.
    • (1992) J. Clin. Endocrinol. Metab. , vol.75 , pp. 762-767
    • Counts, D.R.1    Gwirtsman, H.2    Carlsson, L.M.3    Lesem, M.4    Cutler, G.B.5
  • 127
    • 0036078286 scopus 로고    scopus 로고
    • Effects of recombinant human IGF-1 and oral contraceptive administration on bone density in anorexia nervosa
    • Grinspoon S., Thomas L., Miller K.K., Herzog D.B., Klibaski A. Effects of recombinant human IGF-1 and oral contraceptive administration on bone density in anorexia nervosa. J. Clin. Endocrinol. Metab. 2002, 87:2883-2891.
    • (2002) J. Clin. Endocrinol. Metab. , vol.87 , pp. 2883-2891
    • Grinspoon, S.1    Thomas, L.2    Miller, K.K.3    Herzog, D.B.4    Klibaski, A.5
  • 128
    • 0015788980 scopus 로고
    • Epidemiology of secondary amenorrhea. Incidence and prevalence rates
    • Petersson F., Fries H., Nillius S.J. Epidemiology of secondary amenorrhea. Incidence and prevalence rates. Am. J. Obstet. Gynecol. 1973, 117:80-86.
    • (1973) Am. J. Obstet. Gynecol. , vol.117 , pp. 80-86
    • Petersson, F.1    Fries, H.2    Nillius, S.J.3
  • 129
    • 0022494409 scopus 로고
    • Increase in bone mass after treatment of hyperprolactinemic amenorrhea
    • Klibanski A., Greenspan S.L. Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N. Engl. J. Med. 1986, 315:542-546.
    • (1986) N. Engl. J. Med. , vol.315 , pp. 542-546
    • Klibanski, A.1    Greenspan, S.L.2
  • 134
    • 0023218330 scopus 로고
    • Forearm and vertebral bone mineral in treated and untreated hyperprolactinemia amenorrhea
    • Schlechte J., El-Khoury G., Kathol N., Walkner L. Forearm and vertebral bone mineral in treated and untreated hyperprolactinemia amenorrhea. J. Clin. Endocrinol. Metab. 1987, 64:1021-1026.
    • (1987) J. Clin. Endocrinol. Metab. , vol.64 , pp. 1021-1026
    • Schlechte, J.1    El-Khoury, G.2    Kathol, N.3    Walkner, L.4
  • 137
    • 0024509604 scopus 로고
    • Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism
    • Greenspan S.L., Oppenheim D.S., Klibanski A. Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann. Intern. Med. 1989, 110:526-531.
    • (1989) Ann. Intern. Med. , vol.110 , pp. 526-531
    • Greenspan, S.L.1    Oppenheim, D.S.2    Klibanski, A.3
  • 138
    • 0026783954 scopus 로고
    • A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolatinemia
    • Schlechte J., Walkner L., Kathol M. A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolatinemia. J. Clin. Endocrinol. Metab. 1992, 75:698-703.
    • (1992) J. Clin. Endocrinol. Metab. , vol.75 , pp. 698-703
    • Schlechte, J.1    Walkner, L.2    Kathol, M.3
  • 140
    • 0028787969 scopus 로고
    • Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH- related peptide levels
    • Kovacs C.S., Chik C.L. Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH- related peptide levels. J. Clin. Endocrinol. Metab. 1995, 80:3036-3042.
    • (1995) J. Clin. Endocrinol. Metab. , vol.80 , pp. 3036-3042
    • Kovacs, C.S.1    Chik, C.L.2
  • 142
    • 0025325120 scopus 로고
    • Osteocalcin levels in patients with microprolactinoma before and during medical treatment
    • Sartorio A., Conti A., Ambrosi B., Muratori M., Faglia G. Osteocalcin levels in patients with microprolactinoma before and during medical treatment. J. Endocrinol. Invest. 1990, 13:419-422.
    • (1990) J. Endocrinol. Invest. , vol.13 , pp. 419-422
    • Sartorio, A.1    Conti, A.2    Ambrosi, B.3    Muratori, M.4    Faglia, G.5
  • 143
  • 144
    • 1642484482 scopus 로고    scopus 로고
    • Bone health in pediatric epilepsy
    • Sheth R.D. Bone health in pediatric epilepsy. Epilepsy Behav. 2004, 5:S30-S35.
    • (2004) Epilepsy Behav. , vol.5
    • Sheth, R.D.1
  • 145
    • 0014940394 scopus 로고
    • Osteomalacia with long-term anticonvulsant therapy in epilepsy
    • Dent C., Richens A., Rowe D.F.J., Stamp T. Osteomalacia with long-term anticonvulsant therapy in epilepsy. B.M.J. 1970, 4:69-72.
    • (1970) B.M.J. , vol.4 , pp. 69-72
    • Dent, C.1    Richens, A.2    Rowe, D.F.J.3    Stamp, T.4
  • 146
    • 0014940414 scopus 로고
    • Disturbance of calcium metabolism by antocomvulsant drugs
    • Richens A., Rowe D.F.J. Disturbance of calcium metabolism by antocomvulsant drugs. B. M. J. 1970, 4:73-76.
    • (1970) B. M. J. , vol.4 , pp. 73-76
    • Richens, A.1    Rowe, D.F.J.2
  • 147
    • 0036094249 scopus 로고    scopus 로고
    • Antiepileptic drug-induced bone loss in young male patients who have seizures
    • Andress D.L., Ozuna J., Tirschwell D., et al. Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch. Neurol. 2002, 59:781-786.
    • (2002) Arch. Neurol. , vol.59 , pp. 781-786
    • Andress, D.L.1    Ozuna, J.2    Tirschwell, D.3
  • 149
    • 0033002623 scopus 로고    scopus 로고
    • Bone mineral density of epileptic patients on long-term antiepileptic drug therapy: a quantitative digital radiography study
    • Kubota F., Kifune A., Shibata N., Akata T., Takeuchi K., Takahashi S., Ohsawa M., Takama F. Bone mineral density of epileptic patients on long-term antiepileptic drug therapy: a quantitative digital radiography study. Epilepsy Res. 1999, 33:93-97.
    • (1999) Epilepsy Res. , vol.33 , pp. 93-97
    • Kubota, F.1    Kifune, A.2    Shibata, N.3    Akata, T.4    Takeuchi, K.5    Takahashi, S.6    Ohsawa, M.7    Takama, F.8
  • 150
    • 0038305810 scopus 로고    scopus 로고
    • Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs
    • Pack A.M., Olarte M., Morrell M.J., Flaster E., Resor S.R., Shane E. Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav. 2003, 4:169-174.
    • (2003) Epilepsy Behav. , vol.4 , pp. 169-174
    • Pack, A.M.1    Olarte, M.2    Morrell, M.J.3    Flaster, E.4    Resor, S.R.5    Shane, E.6
  • 151
    • 0035859862 scopus 로고    scopus 로고
    • Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy
    • Sato Y., Kondo I., Ishida S., et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 2001, 57:445-449.
    • (2001) Neurology , vol.57 , pp. 445-449
    • Sato, Y.1    Kondo, I.2    Ishida, S.3
  • 152
    • 0028292967 scopus 로고
    • Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs
    • Valimaki M.J., Tiihonen M., Laitimen K., Tahtela R., Karkkainen M., Lamberg-Allardt C., Makela P., Tunninen R. Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J. Bone Miner. Res. 1994, 9:631-637.
    • (1994) J. Bone Miner. Res. , vol.9 , pp. 631-637
    • Valimaki, M.J.1    Tiihonen, M.2    Laitimen, K.3    Tahtela, R.4    Karkkainen, M.5    Lamberg-Allardt, C.6    Makela, P.7    Tunninen, R.8
  • 153
    • 1642484481 scopus 로고    scopus 로고
    • Fractures, epilepsy, and anticonvulsant drugs
    • Mattson R.H., Gidal B.E. Fractures, epilepsy, and anticonvulsant drugs. Epilepsy Behav. 2004, 5:S36-S40.
    • (2004) Epilepsy Behav. , vol.5
    • Mattson, R.H.1    Gidal, B.E.2
  • 154
    • 0030042219 scopus 로고    scopus 로고
    • Incidence of five common fracture types in an institutional epileptic population
    • Desai K.B., Ribbans W.J., Taylor G.J. Incidence of five common fracture types in an institutional epileptic population. Injury 1996, 27:97-100.
    • (1996) Injury , vol.27 , pp. 97-100
    • Desai, K.B.1    Ribbans, W.J.2    Taylor, G.J.3
  • 156
    • 0036798939 scopus 로고    scopus 로고
    • Central nervous system-actvei medications and risk for falls in older women
    • Ensrud K.E., Blackwell T.L., Mangione C.M., et al. Central nervous system-actvei medications and risk for falls in older women. J. Am. Geriatr. Soc. 2002, 50:1629-1637.
    • (2002) J. Am. Geriatr. Soc. , vol.50 , pp. 1629-1637
    • Ensrud, K.E.1    Blackwell, T.L.2    Mangione, C.M.3
  • 157
    • 1642566108 scopus 로고    scopus 로고
    • Pathophysiology of bone loss in patients receiving anticonvulsant therapy
    • Fitzpatrick L.A. Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav. 2004, 5:S3-S15.
    • (2004) Epilepsy Behav. , vol.5
    • Fitzpatrick, L.A.1
  • 159
    • 0015492164 scopus 로고
    • Effect of chronic anticonvulsant therapy on serum 25-hydroxycholecalciferol levels in adults
    • Hahn T.J., Hendin B.A., Scharp C.R., Haddad J.G. Effect of chronic anticonvulsant therapy on serum 25-hydroxycholecalciferol levels in adults. N. Engl. J. Med. 1972, 287:900-904.
    • (1972) N. Engl. J. Med. , vol.287 , pp. 900-904
    • Hahn, T.J.1    Hendin, B.A.2    Scharp, C.R.3    Haddad, J.G.4
  • 160
  • 161
    • 0016662601 scopus 로고
    • Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy
    • Hahn T.J., Hendin B.A., Scharp C.R., Boisseau V.C., Haddad J.J.G. Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy. N. Engl. J. Med. 1975, 292:550-554.
    • (1975) N. Engl. J. Med. , vol.292 , pp. 550-554
    • Hahn, T.J.1    Hendin, B.A.2    Scharp, C.R.3    Boisseau, V.C.4    Haddad, J.J.G.5
  • 162
    • 0015497261 scopus 로고
    • Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs
    • Stamp T.C.B., Round J.M., Rowe D.J.F., Haddad J.J.G. Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs. B. M. J. 1972, 4:9-12.
    • (1972) B. M. J. , vol.4 , pp. 9-12
    • Stamp, T.C.B.1    Round, J.M.2    Rowe, D.J.F.3    Haddad, J.J.G.4
  • 163
    • 0022515632 scopus 로고
    • A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy
    • Gough H., Goggin T., Bissessar A., Baker M., Crowlay M., Callaghan N. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q. J. Med. 1986, 230:569-577.
    • (1986) Q. J. Med. , vol.230 , pp. 569-577
    • Gough, H.1    Goggin, T.2    Bissessar, A.3    Baker, M.4    Crowlay, M.5    Callaghan, N.6
  • 165
    • 0025817664 scopus 로고
    • Isoenzymes of alkaline phosphatase in epileptic patients receiving carbamazepine monotherapy
    • Okesina A.B., Donaldson D., Lascelles P.T. Isoenzymes of alkaline phosphatase in epileptic patients receiving carbamazepine monotherapy. J. Clin. Pathol. 1991, 44:480-482.
    • (1991) J. Clin. Pathol. , vol.44 , pp. 480-482
    • Okesina, A.B.1    Donaldson, D.2    Lascelles, P.T.3
  • 166
    • 0021080595 scopus 로고
    • Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin
    • Davie M.W., Emberson C.E., Lawson D.E., Roberts G.E., Barnes J.L., Barnes N.D., Heeleg A.F. Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin. D. Q. J. Med. 1983, 205:79-91.
    • (1983) D. Q. J. Med. , vol.205 , pp. 79-91
    • Davie, M.W.1    Emberson, C.E.2    Lawson, D.E.3    Roberts, G.E.4    Barnes, J.L.5    Barnes, N.D.6    Heeleg, A.F.7
  • 167
    • 0019980298 scopus 로고
    • Serum vitamin D metabolites in epileptic patients treated with 2 different anyconvulsants
    • Tjellesen L., Christiansen C. Serum vitamin D metabolites in epileptic patients treated with 2 different anyconvulsants. Acta. Neurol. Scand. 1982, 66:335-341.
    • (1982) Acta. Neurol. Scand. , vol.66 , pp. 335-341
    • Tjellesen, L.1    Christiansen, C.2
  • 169
    • 0021238171 scopus 로고
    • Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment
    • Weinstein R.S., Bryce G.F., Sappington L.J., King D.W., Gallagher B.B. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. J. Clin. Endocrinol. Metab. 1984, 58:1003-1009.
    • (1984) J. Clin. Endocrinol. Metab. , vol.58 , pp. 1003-1009
    • Weinstein, R.S.1    Bryce, G.F.2    Sappington, L.J.3    King, D.W.4    Gallagher, B.B.5
  • 171
    • 0015466657 scopus 로고
    • Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat
    • Koch H.C., Kraft D., Herrath D.V. Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat. Epilepsia 1972, 13:829-841.
    • (1972) Epilepsia , vol.13 , pp. 829-841
    • Koch, H.C.1    Kraft, D.2    Herrath, D.V.3
  • 172
    • 0017046544 scopus 로고
    • Inhibition of vitamin D-stimulated active transport of calcium of rat intestine by diphenylhydantoin phenobarbital treatment
    • Harrison H.C., Harrison H.E. Inhibition of vitamin D-stimulated active transport of calcium of rat intestine by diphenylhydantoin phenobarbital treatment. Proc. Soc. Exp. Biol. Med. 1976, 153:220-224.
    • (1976) Proc. Soc. Exp. Biol. Med. , vol.153 , pp. 220-224
    • Harrison, H.C.1    Harrison, H.E.2
  • 173
    • 0018697229 scopus 로고
    • Anticonvulsant drug-induced osteomalacia: Alterations in mineral metabolism and response to vitamin D3 administration
    • Hahn T.J., Halstead L.R. Anticonvulsant drug-induced osteomalacia: Alterations in mineral metabolism and response to vitamin D3 administration. Calcif. Tissue Int. 1979, 27:13-18.
    • (1979) Calcif. Tissue Int. , vol.27 , pp. 13-18
    • Hahn, T.J.1    Halstead, L.R.2
  • 174
    • 0018139085 scopus 로고
    • Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hornonal mediation of fetal rat bone resorption in vitro
    • Hahn T.J., Scharp C.R., Richardson C.A., Halstead L.R., Kahn A.J., Teitelbaum S.L. Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hornonal mediation of fetal rat bone resorption in vitro. J. Clin. Invest. 1978, 62:406-414.
    • (1978) J. Clin. Invest. , vol.62 , pp. 406-414
    • Hahn, T.J.1    Scharp, C.R.2    Richardson, C.A.3    Halstead, L.R.4    Kahn, A.J.5    Teitelbaum, S.L.6
  • 175
    • 0016217368 scopus 로고
    • The effect of phenytoin on parathyroid extract and 25-hydroxycholecalciferol-induced bone resorption: Adenosine 3?, 5?-cyclic monophosphate production
    • Jenkins M.V., Harris M., Willis M.R. The effect of phenytoin on parathyroid extract and 25-hydroxycholecalciferol-induced bone resorption: Adenosine 3?, 5?-cyclic monophosphate production. Calcif. Tissue Res. 1974, 16:163-167.
    • (1974) Calcif. Tissue Res. , vol.16 , pp. 163-167
    • Jenkins, M.V.1    Harris, M.2    Willis, M.R.3
  • 176
    • 0018844367 scopus 로고
    • Effects of diphenylhydantoin on synthesis of collagen and noncollagen protein in tissue culture
    • Dietrich J.W., Duffield R. Effects of diphenylhydantoin on synthesis of collagen and noncollagen protein in tissue culture. Endocrinology 1980, 106:606-610.
    • (1980) Endocrinology , vol.106 , pp. 606-610
    • Dietrich, J.W.1    Duffield, R.2
  • 177
    • 0032997194 scopus 로고    scopus 로고
    • Estrogen supplementation for bone dematuration in young epileptic man treated with anticonvulsant therapy; a case report
    • Yamano Y., Sakane S., Takamatsu J., Ohsawa N. Estrogen supplementation for bone dematuration in young epileptic man treated with anticonvulsant therapy; a case report. Endocr. J. 1999, 46:301-307.
    • (1999) Endocr. J. , vol.46 , pp. 301-307
    • Yamano, Y.1    Sakane, S.2    Takamatsu, J.3    Ohsawa, N.4
  • 178
    • 0026062955 scopus 로고
    • Phenytoin-induced elevaion of serum estradiol and reproductive dysfunction in men with epilepsy
    • Heroz A.G., Levesque L.A., Drislane F.W., Ronthal M., Schomer D.L. Phenytoin-induced elevaion of serum estradiol and reproductive dysfunction in men with epilepsy. Epilepsia 1991, 32:550-553.
    • (1991) Epilepsia , vol.32 , pp. 550-553
    • Heroz, A.G.1    Levesque, L.A.2    Drislane, F.W.3    Ronthal, M.4    Schomer, D.L.5
  • 179
    • 0002959924 scopus 로고
    • Dynamic differences in trabecular bone remodeling between patients after jejuno-ileal bypass for obesity and epileptic patients receiving anticonvulsant therapy
    • Mosekilde L., Melsen F. Dynamic differences in trabecular bone remodeling between patients after jejuno-ileal bypass for obesity and epileptic patients receiving anticonvulsant therapy. Metab. Bone Dis. Relat. Res. 1980, 2:77-82.
    • (1980) Metab. Bone Dis. Relat. Res. , vol.2 , pp. 77-82
    • Mosekilde, L.1    Melsen, F.2
  • 182
    • 0022978930 scopus 로고
    • Different metabolism of vitamin D2/D3 in epileptic patients treated with phenobarbitone/phenytoin
    • Tjellesen L., Hummer L., Christiansen C., Rodbro P. Different metabolism of vitamin D2/D3 in epileptic patients treated with phenobarbitone/phenytoin. Bone 1986, 7:337-342.
    • (1986) Bone , vol.7 , pp. 337-342
    • Tjellesen, L.1    Hummer, L.2    Christiansen, C.3    Rodbro, P.4
  • 184
    • 0034008836 scopus 로고    scopus 로고
    • Increased bone turnover in epileptic patients treated with carbamazepine
    • Verrotti A., Greco R., Morgese G., Chiarelli F. Increased bone turnover in epileptic patients treated with carbamazepine. Ann. Neurol. 2000, 47:385-388.
    • (2000) Ann. Neurol. , vol.47 , pp. 385-388
    • Verrotti, A.1    Greco, R.2    Morgese, G.3    Chiarelli, F.4
  • 185
    • 0036896976 scopus 로고    scopus 로고
    • Increased bone turnover in prepubertal, pubertal and post-pubertal patients receiving carbamazepine
    • Verrotti A., Greco R., Latini G., Morgese G., Chiarelli F. Increased bone turnover in prepubertal, pubertal and post-pubertal patients receiving carbamazepine. Epilepsia 2002, 43:1488-1492.
    • (2002) Epilepsia , vol.43 , pp. 1488-1492
    • Verrotti, A.1    Greco, R.2    Latini, G.3    Morgese, G.4    Chiarelli, F.5
  • 187
    • 1642566070 scopus 로고    scopus 로고
    • Treatment of anticonvulsant drug-induced bone disease
    • Drezner M.K. Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav. 2004, 5:S41-S47.
    • (2004) Epilepsy Behav. , vol.5
    • Drezner, M.K.1
  • 188
    • 0018853236 scopus 로고
    • Bone mineral status measured by direct photon absorptiometry in institutionalized adults receiving long-term anticonvulsant therapy and multivitamin supplementation
    • Barden H.S., Mazess R.B., Rose P.G., McAweeney W. Bone mineral status measured by direct photon absorptiometry in institutionalized adults receiving long-term anticonvulsant therapy and multivitamin supplementation. Calcif. Tissue Int. 1980, 31:117-121.
    • (1980) Calcif. Tissue Int. , vol.31 , pp. 117-121
    • Barden, H.S.1    Mazess, R.B.2    Rose, P.G.3    McAweeney, W.4
  • 189
    • 0026011883 scopus 로고
    • A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia
    • Collins N., Maher J., Cole M., Baker M., Callaghan N. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia. Quart. J. Med. 1991, 78:113-122.
    • (1991) Quart. J. Med. , vol.78 , pp. 113-122
    • Collins, N.1    Maher, J.2    Cole, M.3    Baker, M.4    Callaghan, N.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.